Teng Feng, Fan Wenjun, Luo Yanrong, Xu Shouping, Gong Hanshun, Ge Ruigang, Zhang Xinxin, Wang Xiaoning, Ma Lin
Department of Radiation Oncology, China-Japan Friendship Hospital, Beijing, China.
Department of Radiation Oncology, Medical School of the Chinese People's Liberation Army (PLA), Beijing, China.
Front Oncol. 2021 Feb 26;11:633556. doi: 10.3389/fonc.2021.633556. eCollection 2021.
This study aimed to develop a least absolute shrinkage and selection operator (LASSO)-based multivariable normal tissue complication probability (NTCP) model to predict radiation-induced xerostomia in patients with nasopharyngeal carcinoma (NPC) treated with comprehensive salivary gland-sparing helical tomotherapy technique.
LASSO with the extended bootstrapping technique was used to build multivariable NTCP models to predict factors of patient-reported xerostomia relieved by 50% and 80% compared with the level at the end of radiation therapy within 1 year and 2 years, R50-1year and R80-2years, in 203 patients with NPC. The model assessment was based on 10-fold cross-validation and the area under the receiver operating characteristic curve (AUC).
The prediction model by LASSO with 10-fold cross-validation showed that radiation-induced xerostomia recovery could be predicted by prognostic factors of R50-1year (age, gender, T stage, UICC/AJCC stage, parotid Dmean, oral cavity Dmean, and treatment options) and R80-2years (age, gender, T stage, UICC/AJCC stage, oral cavity Dmean, N stage, and treatment options). These prediction models also demonstrated a good performance by the AUC.
The prediction models of R50-1year and R80-2years by LASSO with 10-fold cross-validation were recommended to validate the NTCP model before comprehensive salivary gland-sparing radiation therapy in patients with NPC.
本研究旨在开发一种基于最小绝对收缩与选择算子(LASSO)的多变量正常组织并发症概率(NTCP)模型,以预测采用保留唾液腺的螺旋断层放射治疗技术治疗的鼻咽癌(NPC)患者放射性口干的发生情况。
采用带有扩展自抽样技术的LASSO构建多变量NTCP模型,以预测203例NPC患者在放疗结束后1年内和2年内,患者报告的口干缓解50%和80%的相关因素,即R50 - 1年和R80 - 2年。模型评估基于10折交叉验证和受试者操作特征曲线下面积(AUC)。
采用10折交叉验证的LASSO预测模型显示,R50 - 1年(年龄、性别、T分期、UICC/AJCC分期、腮腺平均剂量、口腔平均剂量和治疗方案)和R80 - 2年(年龄、性别、T分期、UICC/AJCC分期、口腔平均剂量、N分期和治疗方案)的预后因素可预测放射性口干的恢复情况。这些预测模型的AUC也显示出良好的性能。
建议采用10折交叉验证的LASSO建立的R50 - 1年和R80 - 2年预测模型,在NPC患者进行保留唾液腺的全面放射治疗前对NTCP模型进行验证。